Intravenous (IV) Solutions Market Report

Global Intravenous (IV) Solutions Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Feb 23, 2022
  • PAGES：222
  • REPORT CODE：GMM763613
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Intravenous (IV) Solutions market report explains the definition, types, applications, major countries, and major players of the Intravenous (IV) Solutions market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Baxter (US)

    • ICU Medical Inc (US)

    • Terumo Medical Corporation (Tokyo)

    • Fresenius Kabi AG (Germany)

    • Amanta Healthcare (India)

    • B Braun Melsungen AG (Germany)

    • Grifols SA (Spain)

    By Type:

    • Peripheral Parenteral Nutrition

    • Total Parenteral Nutrition

    By End-User:

    • Hospital & Clinics

    • Ambulatory

    • Home Care

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Intravenous (IV) Solutions Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Intravenous (IV) Solutions Outlook to 2028- Original Forecasts

    • 2.2 Intravenous (IV) Solutions Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Intravenous (IV) Solutions Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Intravenous (IV) Solutions Market- Recent Developments

    • 6.1 Intravenous (IV) Solutions Market News and Developments

    • 6.2 Intravenous (IV) Solutions Market Deals Landscape

    7 Intravenous (IV) Solutions Raw Materials and Cost Structure Analysis

    • 7.1 Intravenous (IV) Solutions Key Raw Materials

    • 7.2 Intravenous (IV) Solutions Price Trend of Key Raw Materials

    • 7.3 Intravenous (IV) Solutions Key Suppliers of Raw Materials

    • 7.4 Intravenous (IV) Solutions Market Concentration Rate of Raw Materials

    • 7.5 Intravenous (IV) Solutions Cost Structure Analysis

      • 7.5.1 Intravenous (IV) Solutions Raw Materials Analysis

      • 7.5.2 Intravenous (IV) Solutions Labor Cost Analysis

      • 7.5.3 Intravenous (IV) Solutions Manufacturing Expenses Analysis

    8 Global Intravenous (IV) Solutions Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Intravenous (IV) Solutions Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Intravenous (IV) Solutions Export by Region (Top 10 Countries) (2017-2028)

    9 Global Intravenous (IV) Solutions Market Outlook by Types and Applications to 2022

    • 9.1 Global Intravenous (IV) Solutions Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Peripheral Parenteral Nutrition Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Total Parenteral Nutrition Consumption and Growth Rate (2017-2022)

    • 9.2 Global $Intravenous (IV) Solutions Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital & Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Ambulatory Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Home Care Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Intravenous (IV) Solutions Market Analysis and Outlook till 2022

    • 10.1 Global Intravenous (IV) Solutions Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.2.2 Canada Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.2.3 Mexico Intravenous (IV) Solutions Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.3.2 UK Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.3.3 Spain Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.3.4 Belgium Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.3.5 France Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.3.6 Italy Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.3.7 Denmark Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.3.8 Finland Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.3.9 Norway Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.3.10 Sweden Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.3.11 Poland Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.3.12 Russia Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.3.13 Turkey Intravenous (IV) Solutions Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.4.2 Japan Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.4.3 India Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.4.4 South Korea Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.4.5 Pakistan Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.4.6 Bangladesh Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.4.7 Indonesia Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.4.8 Thailand Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.4.9 Singapore Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.4.10 Malaysia Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.4.11 Philippines Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.4.12 Vietnam Intravenous (IV) Solutions Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.5.2 Colombia Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.5.3 Chile Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.5.4 Argentina Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.5.5 Venezuela Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.5.6 Peru Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.5.7 Puerto Rico Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.5.8 Ecuador Intravenous (IV) Solutions Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.6.2 Kuwait Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.6.3 Oman Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.6.4 Qatar Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Intravenous (IV) Solutions Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.7.2 South Africa Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.7.3 Egypt Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.7.4 Algeria Intravenous (IV) Solutions Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Intravenous (IV) Solutions Consumption (2017-2022)

      • 10.8.2 New Zealand Intravenous (IV) Solutions Consumption (2017-2022)

    11 Global Intravenous (IV) Solutions Competitive Analysis

    • 11.1 Baxter (US)

      • 11.1.1 Baxter (US) Company Details

      • 11.1.2 Baxter (US) Intravenous (IV) Solutions Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Baxter (US) Intravenous (IV) Solutions Main Business and Markets Served

      • 11.1.4 Baxter (US) Intravenous (IV) Solutions Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 ICU Medical Inc (US)

      • 11.2.1 ICU Medical Inc (US) Company Details

      • 11.2.2 ICU Medical Inc (US) Intravenous (IV) Solutions Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 ICU Medical Inc (US) Intravenous (IV) Solutions Main Business and Markets Served

      • 11.2.4 ICU Medical Inc (US) Intravenous (IV) Solutions Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Terumo Medical Corporation (Tokyo)

      • 11.3.1 Terumo Medical Corporation (Tokyo) Company Details

      • 11.3.2 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Main Business and Markets Served

      • 11.3.4 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Fresenius Kabi AG (Germany)

      • 11.4.1 Fresenius Kabi AG (Germany) Company Details

      • 11.4.2 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Main Business and Markets Served

      • 11.4.4 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Amanta Healthcare (India)

      • 11.5.1 Amanta Healthcare (India) Company Details

      • 11.5.2 Amanta Healthcare (India) Intravenous (IV) Solutions Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Amanta Healthcare (India) Intravenous (IV) Solutions Main Business and Markets Served

      • 11.5.4 Amanta Healthcare (India) Intravenous (IV) Solutions Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 B Braun Melsungen AG (Germany)

      • 11.6.1 B Braun Melsungen AG (Germany) Company Details

      • 11.6.2 B Braun Melsungen AG (Germany) Intravenous (IV) Solutions Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 B Braun Melsungen AG (Germany) Intravenous (IV) Solutions Main Business and Markets Served

      • 11.6.4 B Braun Melsungen AG (Germany) Intravenous (IV) Solutions Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Grifols SA (Spain)

      • 11.7.1 Grifols SA (Spain) Company Details

      • 11.7.2 Grifols SA (Spain) Intravenous (IV) Solutions Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Grifols SA (Spain) Intravenous (IV) Solutions Main Business and Markets Served

      • 11.7.4 Grifols SA (Spain) Intravenous (IV) Solutions Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    12 Global Intravenous (IV) Solutions Market Outlook by Types and Applications to 2028

    • 12.1 Global Intravenous (IV) Solutions Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Peripheral Parenteral Nutrition Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Total Parenteral Nutrition Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Intravenous (IV) Solutions Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospital & Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Ambulatory Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Home Care Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Intravenous (IV) Solutions Market Analysis and Outlook to 2028

    • 13.1 Global Intravenous (IV) Solutions Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.2.2 Canada Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Intravenous (IV) Solutions Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.3.2 UK Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.3.3 Spain Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.3.5 France Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.3.6 Italy Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.3.8 Finland Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.3.9 Norway Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.3.11 Poland Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.3.12 Russia Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Intravenous (IV) Solutions Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.4.2 Japan Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.4.3 India Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Intravenous (IV) Solutions Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.5.3 Chile Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.5.6 Peru Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Intravenous (IV) Solutions Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.6.3 Oman Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Intravenous (IV) Solutions Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Intravenous (IV) Solutions Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Intravenous (IV) Solutions Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Intravenous (IV) Solutions Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Intravenous (IV) Solutions

    • Figure of Intravenous (IV) Solutions Picture

    • Table Global Intravenous (IV) Solutions Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Intravenous (IV) Solutions Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Peripheral Parenteral Nutrition Consumption and Growth Rate (2017-2022)

    • Figure Global Total Parenteral Nutrition Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital & Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Ambulatory Consumption and Growth Rate (2017-2022)

    • Figure Global Home Care Consumption and Growth Rate (2017-2022)

    • Figure Global Intravenous (IV) Solutions Consumption by Country (2017-2022)

    • Table North America Intravenous (IV) Solutions Consumption by Country (2017-2022)

    • Figure United States Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Canada Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Mexico Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Table Europe Intravenous (IV) Solutions Consumption by Country (2017-2022)

    • Figure Germany Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure UK Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Spain Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Belgium Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure France Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Italy Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Denmark Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Finland Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Norway Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Sweden Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Poland Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Russia Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Turkey Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Table APAC Intravenous (IV) Solutions Consumption by Country (2017-2022)

    • Figure China Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Japan Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure India Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure South Korea Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Thailand Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Singapore Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Philippines Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Table South America Intravenous (IV) Solutions Consumption by Country (2017-2022)

    • Figure Brazil Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Colombia Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Chile Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Argentina Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Peru Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Table GCC Intravenous (IV) Solutions Consumption by Country (2017-2022)

    • Figure Bahrain Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Oman Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Qatar Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Table Africa Intravenous (IV) Solutions Consumption by Country (2017-2022)

    • Figure Nigeria Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure South Africa Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Egypt Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure Algeria Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Table Oceania Intravenous (IV) Solutions Consumption by Country (2017-2022)

    • Figure Australia Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Intravenous (IV) Solutions Consumption and Growth Rate (2017-2022)

    • Table Baxter (US) Company Details

    • Table Baxter (US) Intravenous (IV) Solutions Sales, Price, Value and Gross Profit (2017-2022)

    • Table Baxter (US) Intravenous (IV) Solutions Main Business and Markets Served

    • Table Baxter (US) Intravenous (IV) Solutions Product Portfolio

    • Table ICU Medical Inc (US) Company Details

    • Table ICU Medical Inc (US) Intravenous (IV) Solutions Sales, Price, Value and Gross Profit (2017-2022)

    • Table ICU Medical Inc (US) Intravenous (IV) Solutions Main Business and Markets Served

    • Table ICU Medical Inc (US) Intravenous (IV) Solutions Product Portfolio

    • Table Terumo Medical Corporation (Tokyo) Company Details

    • Table Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Sales, Price, Value and Gross Profit (2017-2022)

    • Table Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Main Business and Markets Served

    • Table Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Product Portfolio

    • Table Fresenius Kabi AG (Germany) Company Details

    • Table Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Main Business and Markets Served

    • Table Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Product Portfolio

    • Table Amanta Healthcare (India) Company Details

    • Table Amanta Healthcare (India) Intravenous (IV) Solutions Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amanta Healthcare (India) Intravenous (IV) Solutions Main Business and Markets Served

    • Table Amanta Healthcare (India) Intravenous (IV) Solutions Product Portfolio

    • Table B Braun Melsungen AG (Germany) Company Details

    • Table B Braun Melsungen AG (Germany) Intravenous (IV) Solutions Sales, Price, Value and Gross Profit (2017-2022)

    • Table B Braun Melsungen AG (Germany) Intravenous (IV) Solutions Main Business and Markets Served

    • Table B Braun Melsungen AG (Germany) Intravenous (IV) Solutions Product Portfolio

    • Table Grifols SA (Spain) Company Details

    • Table Grifols SA (Spain) Intravenous (IV) Solutions Sales, Price, Value and Gross Profit (2017-2022)

    • Table Grifols SA (Spain) Intravenous (IV) Solutions Main Business and Markets Served

    • Table Grifols SA (Spain) Intravenous (IV) Solutions Product Portfolio

    • Figure Global Peripheral Parenteral Nutrition Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Total Parenteral Nutrition Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital & Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ambulatory Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Home Care Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Intravenous (IV) Solutions Consumption Forecast by Country (2017-2022)

    • Table North America Intravenous (IV) Solutions Consumption Forecast by Country (2017-2022)

    • Figure United States Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Intravenous (IV) Solutions Consumption Forecast by Country (2017-2022)

    • Figure Germany Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Intravenous (IV) Solutions Consumption Forecast by Country (2017-2022)

    • Figure China Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Intravenous (IV) Solutions Consumption Forecast by Country (2017-2022)

    • Figure Brazil Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Intravenous (IV) Solutions Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Intravenous (IV) Solutions Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Intravenous (IV) Solutions Consumption Forecast by Country (2022-2028)

    • Figure Australia Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Intravenous (IV) Solutions Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US